Chemoinformaics analysis of PYROGLUTAMIC-ACID
| Molecular Weight | 129.115 | nRot | 1 |
| Heavy Atom Molecular Weight | 122.059 | nRig | 5 |
| Exact Molecular Weight | 129.043 | nRing | 1 |
| Solubility: LogS | -0.802 | nHRing | 1 |
| Solubility: LogP | -0.692 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 16.5236 |
| nHD | 2 | BPOL | 9.32845 |
| QED | 0.393 |
| Synth | 3.726 |
| Natural Product Likeliness | 0.547 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.022 |
| HIA | 0.029 |
| CACO-2 | -5.198 |
| MDCK | 0.00284978 |
| BBB | 0.248 |
| PPB | 0.150694 |
| VDSS | 1.642 |
| FU | 0.768989 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.1 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.545 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.431 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.041 |
| CL | 3.657 |
| T12 | 0.852 |
| hERG | 0.011 |
| Ames | 0.037 |
| ROA | 0.019 |
| SkinSen | 0.139 |
| Carcinogencity | 0.576 |
| EI | 0.958 |
| Respiratory | 0.765 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.95987 |